Long-acting inhaled bronchodilators for COPD--lack of logic continues.
Long acting inhaled bronchodilators - beta agonists and anti-cholinergic--can improve symptoms, enhance quality of life, increase exercise ability, and reduce exacerbation rates in patients with COPD. PHARMAC needs to change policy so that these patients have easy access to this effective group of drugs.